The striatum is the major component of the basal ganglia and is well known to play a key role in the control of motor function via balanced output from the indirect (iSPNs) and direct pathway striatal projection neurons (dSPNs). Little is known, however, about the molecular genetic mechanisms that control the formation of the iSPNs versus dSPNs. We show here that the SoxE family member, Sox8, is co-expressed with the dSPN markers, Isl1 and Ebf1, in the developing striatum. Moreover, dSPNs, as marked by Isl1-cre fate map, express Sox8 in the embryonic striatum and Sox8-EGFP BAC transgenic mice specifically reveal the direct pathway axons during development. These EGFP 1 axons are first observed to reach their midbrain target, the substantia nigra pars reticulata (SNr), at E14 in the mouse with a robust connection observed already at birth. The selective expression of EGFP in dSPNs of Sox8-EGFP BAC mice is maintained at postnatal timepoints. Sox8 is known to be expressed in oligodendrocyte precursor cells (OPCs) together with other SoxE factors and we show here that the EGFP signal co-localizes with the OPC markers throughout the brain. Finally, we show that Sox8-EGFP BAC mice can be used to interrogate the altered dSPN development in Isl1 conditional mutants including aberrant axonal projections detected already at embryonic timepoints.
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axons are first observed to reach their midbrain target, the substantia nigra pars reticulata (SNr), at E14 in the mouse with a robust connection observed already at birth. The selective expression of EGFP in dSPNs of Sox8-EGFP BAC mice is maintained at postnatal timepoints. Sox8 is known to be expressed in oligodendrocyte precursor cells (OPCs) together with other SoxE factors and we show here that the EGFP signal co-localizes with the OPC markers throughout the brain. Finally, we show that Sox8-EGFP BAC mice can be used to interrogate the altered dSPN development in Isl1 conditional mutants including aberrant axonal projections detected already at embryonic timepoints.
Thus, Sox8 represents an early and specific marker of embryonic dSPNs and the Sox8-EGFP BAC transgenic mice are an excellent tool to study the development of basal ganglia circuitry.
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| I N T R O D U C T I O N
Basal ganglia circuits play a central role in the processing of motor, emotional, and intellectual brain functions (Macpherson, Morita, & Hikida, 2014; Obeso, Rodriguez-Oroz, Stamelou, Bhatia, & Burn, 2014) . The principal structure of the basal ganglia, the striatum (a.k. a. caudate-putamen), contributes to this processing through the two major GABAergic output pathways, which comprise the indirect pathway striatal projection neurons (iSPNs) and direct SPNs (dSPNs) (Gerfen & Surmeier, 2011) . Balanced activity in these two pathways is thought to be essential for normal motor control (Albin, 1995; Albin & Tagle, 1995; Albin, Young, & Penney, 1989; Gerfen & Surmeier, 2011) , Moreover, alterations in the development and/ or function of basal ganglia circuits are believed to underlie aspects of childhood neuropsychatric disorders such as obsessive compulsive disorder (OCD) and attention deficit hyperactivity disorder (ADHD) (Leisman & Melillo, 2013) . Despite this, little is known about the development of these SPN pathways at embryonic or postnatal stages.
SPNs are known to arise from the lateral ganglionic eminence (LGE) located in the ventral telencephalon, largely during the second half of embryogenesis (Deacon et al., 1994; Olsson et al., 1995 Olsson et al., , 1998 Wichterle et al., 2001) . A number of developmental control factors including Gsx1/2, Ascl1, and Dlx genes are expressed by LGE progenitors and have been shown to be required for the normal development of LGEderived neuronal subtypes, including the SPNs (Anderson et al., 1997; Casarosa, Fode, & Guillemot, 1999; Corbin, Gaiano, Machold, Langston, & Fishell, 2000; Long et al., 2009; Pei et al., 2011; Toresson & Campbell, 2001; Toresson, Potter, & Campbell, 2000; Waclaw, Wang, Pei, Ehrman, & Campbell, 2009; Wang, Lufkin, & Rubenstein, 2011; Wang, Waclaw, Allen, Guillemot, & Campbell, 2009; Wang et al., 2013; Yun, Garel, Fischman, & Rubenstein, 2003; Yun, Potter, & Rubenstein, 2001; Yun et al., 2002) . Transcription factors that mark differentiating SPNs in both the indirect and direct pathways include Nolz1/Zfp503, Ctip2, and Foxp1 (Arlotta, Molyneaux, Jabaudon, Yoshida, & Macklis, 2008; Chang et al., 2004; Ko, Chen, Chen, Hao, & Liu, 2013; Tamura, Morikawa, Iwanishi, Hisaoka, & Senba, 2004) . Moreover, Ctip2 and Foxp1 have been shown to be required for the normal differentiation of SPNs (Arlotta et al., 2008; Bacon et al., 2015) . The zinc finger transcription factor Sp9 is expressed by many subventricular zone cells of the LGE, however, it's expression resolves to the iSPNs at postnatal stages and is required for the proliferation and postnatal survival of this SPN subtype (Zhang et al., 2016) . Conversely, the early B cell factor Ebf1, is known to be required for the normal development and connectivity of dSPNs, particularly in the matrix compartment (Garel, Marin, Grosschedl, & Charnay, 1999; Lobo, Karsten, Gray, Geschwind, & Yang, 2006; Lobo, Yeh, & Yang, 2008) . More recently, the LIM homeobox gene Isl, has been shown to be selectively expressed in dSPN progenitors and is required for the survival of newborn dSPNs, already at embryonic stages (Ehrman et al., 2013; Lu, Evans, Hirano, & Liu, 2014; Waclaw et al., 2017) . Not all dSPNs require Isl1 for their survival/differentiation as a portion remain in the Isl1 mutants marked by Ebf1 expression (Ehrman et al., 2013) .
In this study, we have examined the embryonic and postnatal striatal neuron expression of the SoxE factor, Sox8, which has previously been associated with oligodendrocyte precursor cells (OPCs) (Sock, Schmidt, Hermanns-Borgmeyer, Bosl, & Wegner, 2001; Stolt, Lommes, Friedrich, & Wegner, 2004; Stolt, Schmitt, Lommes, Sock, & Wegner, 2005) . In addition to OPCs, we show here that Sox8 specifically marks dSPNs, particularly in the dorsal striatum. Moreover, we have characterized Sox8-EGFP mice and show that the EGFP faithfully represents Sox8 in dSPNs while filling the entire cytoplasm (including processes), making the mice a valuable tool to study the formation of the direct pathway during development. (Ehrman et al., 2013) while tdTomato expressing mice were genotyped as described in (Qin, Madhavan, Waclaw, Nakafuku, & Campbell, 2016) . Two cre mouse lines were used: Isl1 cre/1 mice (Srinivas et al., 2001) , provided by T. Jessell (Columbia University, New reports (Toresson & Campbell, 2001; Toresson et al., 2000; Waclaw et al, 2009) The Sox8 antibody was provided by Dr. Michael Wegner (University of Erlangen-Nuremberg; Bavaria; Germany RRID: AB_2571872).
| MATERIALS A ND METHODS
| Animals
The antibody was generated in guinea pig against a purified bacterially expressed protein consisting of amino acids 2-60 of mouse Sox8 fused to glutathione S-transferase (Stolt et al., 2005) .
The tdTomato immunostaining was performed using a rabbit poly- both N-and C-terminal fusion proteins containing these fluorescent proteins in mammalian cell lysates (manufacturer's datasheet). Specificity was confirmed by immunostaining of tdTomato -brains.
The EGFP antibody was purchased from Aves Labs (cat# GFP-1020, RRID:AB_10000240). IgY fractions obtained from immunized chickens were affinity-purified using an agarose matrix to which the recombinant protein was attached. The antiserum was analyzed by western blot analysis and immunohistochemistry using transgenic mice expressing the GFP gene product (manufacturer's datasheet). No staining was observed in sections of GFP -brains from litter mates.
Anti-FoxP1 was purchased from Abcam and was used to identify the striatal projection neurons (cat# ab57216, RRID:AB_941648). Our immunostaining for FoxP1 shows a distribution pattern in the mouse brain consistent with published reports The rabbit Ebf1 antibody was purchased from Millipore (cat# AB10523, RRID: AB_2636856). According to the manufacturer's datasheet it recognizes Ebf1 but not Ebf2 or Ebf3, from human and mouse origin, in dot blot and in western blot analysis of COS7 transfected cells. Our expression pattern correlates with previous reports (Hua et al., 2014) .
The Nkx2.1 antibody was obtained from Seven Hills Bioreagents (cat# WRAB-1231, RRID: AB_451727). This polyclonal antibody is raised in rabbit and was used to define striatal interneurons as previously described in Marin, Anderson, and Rubenstein (2000) . Our staining is consistent with previous published reports (Marin et al., 2000; Xu, Tam, & Anderson, 2008) .
The Sox9 antibody is a rabbit polyclonal from Santa Cruz Biotechnology which was raised against amino acids 407-496 mapping near the C-terminus of Sox-9 of human origin. A single specific 65 kDa band was observed by western blot on mouse Sox9 transfected cells (cat# sc-20095, RRID:AB_661282).
The goat polyclonal Sox10 antibody was obtained from Santa
Cruz Biotechnology (cat# sc-17342, RRID: AB_2195374). This in the mouse brain (see e.g., Ehrman et al., 2014) .
PDGFRa antibody was obtained from Santa Cruz Biotechnology (cat# sc-338, RRID: AB_631064). This is an affinity purified rabbit polyclonal antibody raised against a peptide mapping to the C-terminal region of human PDGFRa. In western blot, it recognizes a single 170 kDa band on NIH/3T3 whole cell lysates (manufacturer's datasheet).
This antibody has previously been used to identify OPCs in the mouse telencephalon (see e.g., Ehrman et al., 2014) .
The TH antibody was purchased from Aves Labs (cat# TYH, RRID: AB_10013440). Chickens were immunized with two synthetic peptide/ keyhole limpet hemocyanin (KLH) conjugates. These synthetic peptides corresponded to different regions of the Tyrosine Hydroxylase gene product (EC 1.14.16.2). These peptide sequences are shared between the mouse (P24529) and human (P07101) gene products (Erickson et al., 2012) .
Substance P antibody was obtained from Millipore (cat# MAB356, RRID:AB_94639) has been previously used to identify the direct pathway medium-sized spiny neuron collaterals (Gonzales, Pare, Wichmann, & Smith, 2013) . The specificity of the substance P antibody has been demonstrated by showing the equal displacement of labeled Substance P by five-, six-, and eight-amino acid COOH-terminal fragments of Substance P, as well as full-length Substance P, and by the specific binding of these antibodies with cell bodies and terminals located in welldefined Substance P-containing nuclei in the central nervous system.
Our staining results were consistent with that of Gonzales et al. (2013) .
| In situ hybridization
The in situ hybridization procedure was performed as previously described (Toresson, Mata de Urquiza, Fagerstrom, Perlmann, & Campbell, 1999) . Digoxigenin-labeled antisense probes against Sox8 (Clone ID: 6306276: Dharmacon) were used on 12 mm sections of E11.5, E13.5, and E18.5 embryos.
| Imaging and cell counting
Images were captured using a Nikon A1RSi or C2 Inverted Confocal
Microscope or an Olympus BX-51 microscope equipped with epiflourescence and processed when needed for brightness and contrast using Adobe Photoshop CS6 (Adobe Systems Inc., San Jose, CA). Cell counts were done using NIS Elements AR 4.5 software (Nikon Instruments Inc.) on three consecutive 400x confocal pictures from 2 to 3 animals each. Between 1001 and 1325 DAPI 1 cells were analyzed for each staining condition. Images were taken from the central portion of the dorsal striatum at E18.5.
| R E S U L T S 3.1 | Sox8 is present in dSPN progenitors
The HMG box transcription factor, Sox8 is known to be expressed in OPCs and to play a compensatory role in oligodendrogenesis in the absence of either Sox9 or Sox10 (Sock et al., 2001; Stolt et al., 2004 Stolt et al., , 2005 , however, no detailed report on the expression of this factor in neuronal populations exists. A previous study by Sock et al. (2001) , in which lacZ was used to replace the Sox8 locus, showed extensive beta- showed that 59% (Ehrman et al., 2013; Lu et al., 2014) and co-labeled with Sox8 at E15.5 and E18.5 (Figure 1g-k) . The vast majority of tdTomato expressing Isl1 fate mapped cells (i.e., dSPNs) co-express Sox8 at both stages ( Figure 1h ,i,k). Indeed, at E15.5, the vast majority of tdTomatopositive dSPNs in the dorsal striatum were observed to express Sox8
( Figure 1i ). Thus, Sox8 exhibits a complex expression pattern within the
LGE/striatum that partially overlaps with that of Isl1 and Ebf1, particularly in the developing dSPNs (Figure 1l ). Hence, these results suggest that Sox8 represents a new marker of dSPNs in addition to the previously established Isl1 (Ehrman et al., 2013; Lu et al., 2014) and Ebf1 (Lobo et al., 2006 (Lobo et al., , 2008 .
We also performed a comparative analysis of Sox8 gene and protein expression over three stages; E11.5 prior to SPN differentiation, E13.5 an early stage of striatal neurogenesis, and E18.5 near the (Corbin et al., 2000; Toresson & Campbell, 2001; Toresson et al., 2000; Waclaw et al., 2009; Yun et al., 2001 Yun et al., , 2003 . We examined Sox8 gene and protein expression in the Gsx2 RA/RA null mutant ) and found an initial ventral shift of its dorsal limit (Figure 2b,d ), similar to that observed for other ventral telencephalic genes (e.g., Ascl1, Dlx factors) in these mutants (Corbin et al., 2000; Toresson et al., 2000; Yun et al., 2001) . No noticeable change in the VZ expression was observed at later stages in the Gsx2 mutants, however, expression in the forming striatum was notably reduced ( Figure   2f ,h,j,l), as seen for other striatal markers such as, Isl1, in these mutants ) (a, c). By E13.5, Sox8 gene and protein expression expands dorsally in the VZ and is also detected in the developing striatum (e, g). At this stage, Gsx2 mutants (f, h) show no difference in the VZ expression of Sox8, but display a clear reduction in the forming striatum (compare f, h to e, g). At E18.5, Sox8 remains robustly expressed in the striatum (i, k) and is reduced in Gsx2 mutants (j, l). MGE 5 medial ganglionic eminence; LGE 5 lateral ganglionic eminence. Scale bar 5 500 lm (Toresson & Campbell, 2001; Toresson et al., 2000; Waclaw et al., 2009; Wang et al., 2011) . Thus, Sox8 initially behaves similar to ventral telencephalic genes within the VZ at early stages corresponding with the observed patterning defect in striatal development but at later stages the VZ expression appears to be independent of Gsx2 gene function.
| Characterization of Sox8-EGFP BAC mice
A number of BAC transgenic lines have previously been used to fluorescently mark either the iSPNs or dSPNs together with their axonal projections (Ehrman et al., 2013; Lobo et al., 2006 Lobo et al., , 2008 Shuen, Chen, Gloss, & Calakos, 2008; Wang et al., 2006) Many of these BAC transgenes, however, contain genes expressed highly in mature SPNs and thus may not provide robust labeling of the developing SPNs and their axonal trajectories. Given our findings that Sox8 appears to mark the dSPNs at embryonic stages, we examined EGFP expression in Sox8-EGFP BAC transgenic mice generated by the GENSAT project (Gong et al., 2003) to determine if these mice provide a reliable tool to visualize the development of the direct pathway already at embryonic timepoints. Although we were able to detect EGFP expression as early as E12.5 (see Figure 4) we initially focused on E16.5 and E18.5 when the striatal complex is well delineated. First, we compared the expression of EGFP and Sox8 at E16.5 and found that, with the exception of the VZ expression of Sox8 (Figure 3a) , EGFP immunostaining co-labels extensively with Sox8 in the SVZ and developing striatum (particularly the dorsomedial striatal region) (Figure 3a-c) . In addition to the mediolateral gradient of Sox8 (see Figure 1) , both Sox8 and EGFP also show a highdorsal to low-ventral gradient within the striatal complex (Figure 3a-c) .
The SPNs comprise around 90-95% of the cells in the mature striatum (Kemp & Powell, 1971 ) with the remaining 5-10% representing different subtypes of interneurons (Kawaguchi, 1993) . The forkhead transcription factor Foxp1 is known to mark the vast majority of SPNs belonging to both the direct and indirect pathway (Arlotta et al., 2008) . In the Sox8-EGFP striatum at E18.5 staining for Foxp1 showed that the vast majority of the EGFP 1 cells were FoxP1 1 (Figure 3d-f) .
We next co-stained the Sox8-EGFP striatum with dSPN markers and found that 76% of Isl1 1 cells co-express EGFP (Figure 3g tangentially from the medial ganglionic eminence (MGE) and settle in the forming striatum (Marin et al., 2000) . These neurons express the transcription factor Nkx2.1 (Marin et al., 2000) . Double immunostaining for Nkx2.1 and EGFP showed that there is no detectable colocalization between the two markers (Figure 3m-o) , indicating that Sox8-expressing striatal cells are not interneurons. Taken together, Sox8 appears to mark dSPNs and their progenitors from early stages and the Sox8-EGFP BAC mice represent a useful tool for studying this neuronal population at embryonic timepoints.
The defining feature of dSPNs is their axonal projections to the substantia nigra including the pars reticulata (SNr) (Gerfen, 2004) . Thus, we decided to carefully analyze the origin and destination of the EGFP 1 axonal projections in Sox8-EGFP embryos in sagittal sections at different embryonic stages. We first observed EGFP 1 axons emanating from the developing dorsal striatum at E12.5, however, they only extend to the diencephalon at this stage (Figure 4a ). By E14.5, some of the EGFP 1 axons can be observed reaching all the way to the SNr ( Figure   4b ). At E16.5, the EGFP 1 axons projecting to the substantia nigra are numerous and begin arborizing within the SNr (Figure 4c,d) . The neuropeptide substance P is an established marker of the direct pathway SPNs (Gerfen, 2004) . We were able to identify EGFP/Substance P double positive processes in the SNr as early as E16.5 (Figure 4d) , further supporting the notion that Sox8-EGFP neurons are dSPNs. In agreement with the fact that most SPNs are generated by birth, the direct pathway appears to be largely complete by E18.5 (Figure 4f ). The reciprocal nature of the striatonigral and nigrostriatal pathways has been well documented (reviewed in Gerfen, 2004) thus we examined the formation of these intimately associated pathways in the Sox8-EGFP mice.
Indeed, a clear SNc/SNr structure is evident at E16.5 and E18.5 ( Figure   4e ,i). Moreover, the close association of descending dSPN axons and ascending dopamine fibers (marked by tyrosine hydroxlase) can be seen before birth within the internal capsule ( Figure 4h ). This is also true at striatal levels where dopamine terminals show close association with the EGFP 1 (i.e., dSPN) cell bodies (Figure 4g ). Thus, the Sox8-EGFP mice represent a very useful tool to study the formation of basal ganglia circuitry especially as it relates to the direct pathway.
A widely exploited approach to identify dSPNs and iSPNs in the postnatal/adult brain has been to utilize the Drd1-EGFP and Drd2-EGFP BAC transgenic mice (Ehrman et al., 2013; Lobo et al., 2006 Lobo et al., , 2008 Shuen et al., 2008; Wang et al., 2006) . At perinatal timepoints, however, the Drd1-EGFP transgene is only expressed in subsets of SPNs, apparently in the patch (striosomal) compartment (Figure 5a ). Despite the low number of SPNs expressing Drd1-EGFP at birth, most of these neurons also co-expressed Sox8 protein (Figure 5b ). In contrast, the Drd2-EGFP BAC transgene marks large numbers of SPNs throughout the newborn striatal complex (Figure 5c ) and none of these EGFP 1 neurons co-expressed Sox8 (Figure 5d ). To determine how specific the Sox8-EGFP expression was to dSPNs in the postnatal brain, we crossed the mice with Drd1-tdTomato mice (Shuen et al., 2008) and analyzed them at P7, when the Drd1 BAC transgene is expressed throughout the striatal complex (Figure 5f ). Again, at this timepoint, the EGFP from the Sox8-EGFP BAC transgene showed a higher expression level within the dorsal striatum and only weak expression in the ventral striatum, including the nucleus accumbens (Figure 5e ). In line with the embryonic studies described above, we observed a high degree of overlap between the Sox8 driven EGFP and Drd1 driven tdTomato within the dorsal striatum as well as along the direct pathway trajectories ( Figure   5g -k), supporting the notion that Sox8 is an early marker of dSPNs and that Sox8-EGFP BAC mice represent an excellent tool to follow the formation of the direct pathway from embryonic to postnatal stages.
As mentioned above, Sox8 (and Sox8-EGFP) marks a population of cells that are scattered throughout the brain parenchyma including the telencephalon, diencephalon and midbrain resembling migrating OPCs (Figures 2i,k, 4f ). To determine if these Sox8 (and Sox8-EGFP) cells (i.e., direct pathway) and ascending TH 1 (i.e., dopaminergic) fibers is observed along the direct pathway trajectory. (i) Typical organization of the substantia nigra with a TH 1 SNc/VTA dorsal and lateral to the SNr containing EGFP 1 terminals. GP 5 globus pallidus; SNr 5 substantia nigra reticulata; SNc 5 substantia nigra pars compacta; STN 5 subthalamic nucleus; SP 5 substance P; TH 5 tyrosine hydroxylase; VTA 5 ventral tegmental area. Scale bar: in a-c 5 200 lm, g, h 5 10 lm. d, e, i 5 100 lm, f 5 500 lm only able to examine these axonal trajectories at adult timepoints as we were unable to specifically and robustly label the forming direct pathway in embryonic and early postnatal Isl1 conditional mutants (cKOs).
In this study, we have utilized the Sox8-EGFP allele to examine the formation of the direct pathway in Dlx1-cre; Isl1 fl/fl animals at birth (i.e., P0). In contrast to the control animals (Figure 7a ), a clear reduction in EGFP 1 striatal cells and dSPN axons was apparent in the Isl1 cKO brain (Figure 7b ). In addition to the reduced number of EGFP 1 dSPNs in the Isl1 cKO striatum, we observed considerable alterations in the EGFP 1 axonal trajectories along the direct pathway of the conditional mutants ( Figure 7b ). We previously showed that deletion of Isl1 using Dlx5/6-CIE mice resulted in a major loss of reticular thalamus neurons (Ehrman et al., 2013) . Using the Dlx1-cre BAC mice, Isl1 is also severely reduced in the reticular thalamus of the cKO (Figure 7d ). Notably, at the level of the reticular thalamus in these mutants, many EGFP 1 axons were observed to invade the dorsal thalamus in the cKOs, but not the controls (compare Figure 7d with c) . Furthermore, Sox8 protein expression was reduced in the Isl1 cKO striatum (Figure 7f) , as compared to the control (Figure 7e ). This reduction in Sox8 (and EGFP) expression likely reflects the significant cell death phenotype observed in dSPNs of the Isl1 cKOs (Ehrman et al., 2013; Lu et al., 2014) . Therefore, the Sox8-EGFP BAC mice represent an excellent tool to study perturbations to the direct pathway in defined genetic lesions.
| DISCUSSION
The SoxE factors, including Sox8, Sox9, and Sox10 are well known regulators of glial development and in particular OPCs and oligodendrogenesis (Sock et al., 2001; Stolt et al., 2004 Stolt et al., , 2005 . In this study, we have characterized novel neuronal expression of the SoxE factor, Sox8, has been shown to be required for OPC specification while Sox10 plays important roles in oligodendrocyte differentiation (Stolt et al., 2002 (Stolt et al., , 2003 . While Sox8 mutants have only been shown to exhibit a transient delay in terminal differentiation and myelination within the mutant spinal cord (Stolt et al., 2004) , removal of Sox8 from either the Sox9 or Sox10 mutant backgrounds exacerbates both of the phenotypes (Stolt et al., 2004 (Stolt et al., , 2005 . Despite this, it appears that Sox8 is not completely redundant with these SoxE factors, as the replacement of the Sox10 locus with Sox8, does not fully rescue the Sox10 mutant phenotype (Kellerer et al., 2006; Stolt et al., 2005) . Interestingly, this appears to be the first description of a SoxE factor in a defined neuronal subtype lineage. Using Isl1-cre mice (Srinivas et al., 2001 ) to mark the direct pathway (Ehrman et al., 2013; Lu et al., 2014) we demonstrate here that Sox8 is expressed by newborn SPNs and specifically those that belong to the direct pathway (i.e., dSPNs).
Despite the reduction in Sox8 expressing cells within the Isl1 cKO striatum, it appears that at least a portion of the remaining dSPNs in this mutant do express Sox8 and that the loss of Sox8-expressing cells is likely due to the considerable neuronal death occurring within the mutant dSPNs (Ehrman et al., 2013; Lu et al., 2014; Waclaw et al., 2017) . This suggests that Sox8 is not directly regulated by Isl1 and may thus control a parallel pathway in dSPN differentiation. This is in line with the maintained expression of Ebf1 in the remaining dSPNs of the Isl1 cKO mutants (Ehrman et al., 2013; Lu et al., 2014) . Therefore, it will be interesting to determine the relationship between Sox8 and Ebf1, which represents the other major regulator of dSPN development (Lobo et al., 2006 (Lobo et al., , 2008 . Ebf1 has been shown to be expressed in, and required for development of the matrix compartment (Garel et al., 1999) . Moreover, it regulates dSPN development rather specifically within this compartment of the striatum (Lobo et al., 2008) . However, it does not appear that Sox8 is differentially expressed in the matrix versus the patch (striosome) compartment (data not shown) and thus may be regulated by other factors within the developing striatal patches.
We were surprised to observe the ventral restriction of Sox8 gene and protein expression in the VZ of the E11.5 telencephalon given its broad dorsoventral extent within the VZ at later stages. At this early timepoint, Sox8 is subject to dorsoventral patterning constraints typical of most other ventral telencephalon restricted genes. The homeobox gene Gsx2 represents an important regulator of ventral patterning in the telencephalon and is required for normal ventral telencephalic gene expression (Corbin et al., 2000; Toresson et al., 2000; Waclaw et al., 2009; Wang et al., 2013; Yun et al., 2001) . In Gsx2 mutants, we found that the dorsal limit of Sox8 expression is shifted ventral as is the case with other ventral telencephalic regulators such as Ascl1 and Dlx Sox8-EGFP BAC mice have been generated by the GENSAT project (Gong et al., 2003) . Characterizing these mice showed that they mark dSPNs from early stages of striatogenesis as well as considerable numbers of OPCs throughout the brain. Interestingly, the VZ expression of Sox8 was not observed in the Sox8-EGFP BAC mice at any stage analyzed. Thus, the enhancer elements driving this expression are not represented in the BAC used to create these mice. The majority of EGFP 1 neurons in the striatum expressed the dSPN markers, Isl1 (Ehrman et al., 2013; Lu et al., 2014) and Ebf1 (Lobo et al., 2006 (Lobo et al., , 2008 but not the striatal interneuron marker Nkx2.1 (Marin et al., 2000) . At postnatal stages, the Sox8-EGFP transgene showed considerable overlap with the Drd1-tdTomato transgene (Shuen et al., 2008) , at least in dorsal striatal regions where the EGFP signal was most abundant. Similarly, when the EGFP 1 cells with OPC morphologies were investigated, the overwhelming majority coexpressed all of the typical OPC markers. Thus
Sox8-EGFP BAC mice represent a very useful tool to mark the dSPNs from embryonic to postnatal stages as well as large populations of
OPCs. Presumably the developmental history of these EGFP 1 neural subtypes is quite distinct given the restricted generation and migration of dSPNs and the widespread distribution of labeled OPCs. These reporter mice, however, may be useful tools to dissect the lineage relationship between dSPNs and LGE-derived OPCs.
In addition to the cell body labeling, the EGFP expressed in the Sox8-EGFP mice also fills the neuronal processes of labeled cells and thus marks the axons and terminals. This characteristic also helped to define the EGFP 1 cells as dSPNs due to the axonal projections through the internal capsule toward, and into, the SNr. As mentioned above, there is considerable overlap in the EGFP and tdTomato signals in axons of the direct pathway in Sox8-EGFP; Drd1-tdTomato double transgenic mice at postnatal stages. Unlike the Drd2-EGFP BAC transgene which appears to be expressed in large numbers of iSPNs already at embryonic timepoints (Morello et al., 2015) , the Drd1-EGFP BAC transgene is only found in a small subpopulation of dSPNs. Therefore, the Sox8-EGFP BAC transgene allows us to mark the direct pathway already at embryonic stages. Indeed, we observe EGFP expression in neurons within the E12.5 LGE mantle (i.e., forming striatum) of the Sox8-EGFP embryos. At this timepoint, the EGFP 1 axons only reach as far as the diencephalon, however, 2 days later at E14.5 the first EGFP 1 axons can be seen to invade the ventral midbrain in the vicinity of the SNr. A previous study, using retrograde tracing, indicated that the striatonigral axons first reach the midbrain around E17 in the rat (Fishell & van der Kooy, 1987) . This would correlate to about E14.5 in the mouse according to the Translating Time website (http://www.translatingtime.net), as the mouse is approximately 2 days shorter gestation (Workman, Charvet, Clancy, Darlington, & Finlay, 2013) . Thus our findings in the Sox8-EGFP BAC mice support the timing of dSPN innervation of the SNr shown by Fishell and van der Kooy (1987) and indicate that these mice represent a excellent tool to study the formation of this crucial basal ganglia circuit component.
Formation of the direct pathway depends on two major transcription factors Isl1 and Ebf1 (Ehrman et al., 2013; Garel et al., 1999; Lobo et al., 2006 Lobo et al., , 2008 Lu et al., 2014) . Isl1 plays a cell autonomous role in regulating survival of newborn dSPNs and a non-cell autonomous role in regulating the normal formation of the internal capsule in which the direct pathway axons travel (Ehrman et al., 2013; Lu et al., 2014) . Inactivation of Isl1 in the embryonic ventral thalamus results in the loss of the reticular thalamus neurons (Ehrman et al., 2013) , which correlates well with the observed defects in the internal capsule and direct pathway trajectory at postnatal times. We bred the Sox8-EGFP allele onto the Dlx1-cre; Isl1 cKO background to examine the direct pathway at perinatal timepoints and found that numerous EGFP 1 axons aberrantly invade the dorsal thalamus at the level of the reticular thalamus in the Isl1 cKOs at birth. Repulsive Plexin D1-Sema 3e signaling has been proposed to regulate normal internal capsule and direct pathway formation (Chauvet et al., 2007; Ehrman et al., 2013) . In fact, Sema 3e is expressed by the ventral thalamus (precursor to the reticular thalamus)
and Plexin D1 uniquely defines the dSPNs (Chauvet et al., 2007; Ehrman et al., 2013; Lu et al., 2014) . Chauvet et al. (2007) showed that Sema 3e mutants exhibit aberrant innervation of Plexin D1 axons originating from the internal capsule into the reticular thalamus. Moreover, Sema 3e mutants show disruptions in direct pathway axonal trajectories at postnatal stages (Ehrman et al., 2013) . The direct pathway defects observed at the level of the subthalamic nucleus and SNr in postnatal Dlx-cre driven Isl1 cKO appear similar to that observed in the Sema 3e mutants (Ehrman et al., 2013) . However, the aberrant axonal innervation of the dorsal thalamus was not observed in Isl1 cKOs at the postnatal timepoints examined. Using the Sox8-EGFP BAC transgenic mice, we did observe abnormal dSPN innervation of the dorsal thalamus in Dlx1-cre; Isl1 cKOs at birth, suggesting that these aberrantly projecting direct pathway axons are pruned back from the dorsal thalamus at postnatal times. These findings demonstrate the utility of the Sox8-EGFP BAC mice to study the development of basal ganglia circuitry in both wild type and genetic mutant backgrounds.
